Luk Li
Impact in
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Advancements in Transdermal Drug Delivery
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Drug Solubulity and Delivery Systems 4
- Advanced Drug Delivery Systems 3
- Surgery 2
- Co-authors
- Yi Shi (2 shared papers)Shirui Mao (2 shared papers)Andreas Schaper (1 shared paper)Thomas Kissel (1 shared paper)Jing Xu (1 shared paper)David F. Driscoll (1 shared paper)Bruce R. Bistrian (1 shared paper)Vigen K. Babayan (1 shared paper)
- Journals
- Pharmaceutical Development and Technology (2 papers)European Journal of Pharmaceutics and Biopharmaceutics (1 paper)American Journal of Health-System Pharmacy (1 paper)Expert Opinion on Drug Delivery (1 paper)Current Pharmaceutical Design (1 paper)
- Partner nations
- United StatesUnited KingdomChina
In The Last Decade
Luk Li
8 papers receiving 401 citations
Peers
Comparison fields: 5 of 79
- Pharmaceutical Science 188
- Biomaterials 95
- Molecular Medicine 30
- Nutrition and Dietetics 49
- Anesthesiology and Pain Medicine 13
Countries citing papers authored by Luk Li
This map shows the geographic impact of Luk Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luk Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luk Li more than expected).
Fields of papers citing papers by Luk Li
This network shows the impact of papers produced by Luk Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luk Li. The network helps show where Luk Li may publish in the future.
Co-authors
The 15 scholars most cited alongside Luk Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 138 | |
| 2 | 2005 | 106 | |
| 3 | 1995 | 103 | |
| 4 | 2014 | 23 | |
| 5 | 2003 | 15 | |
| 6 | 2002 | 12 | |
| 7 | The development of an injection-molding process for a polyanhydride implant containing gentamicin sulfate. | 2002 | 11 |
| 8 | 2001 | 6 |
About Luk Li
Luk Li is a scholar working on Pharmaceutical Science, Surgery, Biomaterials, Biomedical Engineering and Molecular Biology, having authored 8 papers that have together received 414 indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (4 papers), Advanced Drug Delivery Systems (3 papers), Nanoparticle-Based Drug Delivery (2 papers), Bone Tissue Engineering Materials (2 papers), Protein purification and stability (1 paper), Radiation Effects and Dosimetry (1 paper), Dental materials and restorations (1 paper) and Pain Management and Opioid Use (1 paper). The work is most often cited by research in Pharmaceutical Science (188 citations), Biomaterials (95 citations), Molecular Medicine (30 citations), Nutrition and Dietetics (49 citations) and Anesthesiology and Pain Medicine (13 citations). Luk Li has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Yi Shi, Shirui Mao, Andreas Schaper, Thomas Kissel, Jing Xu, David F. Driscoll, Bruce R. Bistrian, Vigen K. Babayan, Hridaya N. Bhargava and Xin Zhang. Their work appears in journals such as Pharmaceutical Development and Technology, European Journal of Pharmaceutics and Biopharmaceutics, American Journal of Health-System Pharmacy, Expert Opinion on Drug Delivery and Current Pharmaceutical Design.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.